Future glucose-lowering drugs for type 2 diabetes

Keyphrases

• A1 Receptor 66%
• Adiponectin Receptor Agonist 33%
• Biological Agents 33%
• Cardiovascular Disease 33%
• Cell Function 33%
• Cell Mass 33%
• Comorbidity 33%
• Continuous Delivery 33%
• Dipeptidyl peptidase-4 (DPP-4) 33%
• Distant Vision 33%
• Drug Interactions 33%
• Early Development 33%
• Existing Drugs 33%
• Fibroblast Growth Factor 21 (FGF21) 33%
• Formulation Method 33%
• Glucagon Action 33%
• Glucagon-like 66%
• Glucose Homeostasis 33%
• Glucose Metabolism 33%
• Glucose-lowering Drugs 100%
• Hybrid Molecules 33%
• Hypoglycemia 33%
• Incretin 33%
• Incretin-based Therapy 33%
• Insulin Action 33%
• Insulin Receptor 33%
• Insulin Release 33%
• Mode of Delivery 33%
• Multivariable 33%
• Natural History 33%
• New Insulin 33%
• Nonapeptides 33%
• Once-weekly 33%
• Osmotic Pump 33%
• Peptide Molecules 33%
• Peroxisome Proliferator-activated Receptor 33%
• Pharmacological Intervention 33%
• Receptor Agonist 33%
• Receptor Modulators 33%
• Receptor Signaling 33%
• Renal Impairment 33%
• Signaling Cascades 33%
• Small Molecule Inhibitors 33%
• Sodium-glucose Cotransporter Inhibitors 33%
• Treatment Process 33%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Weight Gain 33%

Medicine and Dentistry

• Adiponectin Receptor 50%
• Biological Product 50%
• Cardiovascular Disease 50%
• Cell Function 50%
• Comorbidity 50%
• Dipeptidyl Peptidase-4 Inhibitor 50%
• Drug Interaction 50%
• FGF21 50%
• Glucagon 50%
• Glucagon Like Peptide 1 Receptor 50%
• Glucagon-Like Peptide-1 Agonist 50%
• Glucocorticoid 50%
• Glucose Homeostasis 50%
• Glucose Metabolism 50%
• Hypoglycemia 50%
• Incretin 100%
• Insulin Receptor 50%
• Maturity Onset Diabetes of the Young 100%
• Peroxisome Proliferator Activated Receptor 50%
• Receptor 50%
• Sodium Glucose Cotransporter Inhibitor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Adiponectin Receptor 50%
• Biological Product 50%
• Cardiovascular Disease 50%
• Comorbidity 50%
• Dipeptidyl Peptidase IV Inhibitor 50%
• Drug Interaction 50%
• Fibroblast Growth Factor 21 50%
• Glucagon 50%
• Glucagon Like Peptide 1 Receptor Agonist 50%
• Glucagon-Like Peptide 1 Receptor 50%
• Glucocorticoid 50%
• Hypoglycemia 50%
• Incretin 100%
• Insulin Receptor 50%
• Non Insulin Dependent Diabetes Mellitus 100%
• Peroxisome Proliferator Activated Receptor 50%
• Receptor 50%
• Receptor Agonist 50%
• Sodium Glucose Cotransporter Inhibitor 50%
• Tablet 50%